19:08:51 EDT Tue 04 Aug 2026
Enter Symbol
or Name
USA
CA



Tempramed Technologies Ltd
Symbol VIVI
Shares Issued 78,379,609
Close 2026-08-04 C$ 0.49
Market Cap C$ 38,406,008
Recent Sedar+ Documents

Tempramed forms partnership w/ Stealth Health platform

2026-08-04 16:53 ET - News Release

Ms. Julia Becker reports

TEMPRAMED ANNOUNCES STRATEGIC PARTNERSHIP WITH STEALTH HEALTH, A LEADING TELEMEDICINE PLATFORM FOR LONGEVITY AND WELLNESS

Tempramed Technologies Ltd. has formed a strategic partnership with Stealth Health, a leading telemedicine platform for longevity and precision wellness in North America. The agreement integrates Tempramed's VIVI product portfolio into Stealth Health's growing ecosystem of direct-to-patient care and enterprise white-label telemedicine services, creating a meaningful new distribution channel for medication protection products across North America, and expanding into new key markets.

Through its integrated digital health ecosystem, Stealth Health delivers personalized programs for weight management, hormone optimization, peptides, longevity medicine, sexual wellness, mental health, performance enhancement and preventative care. Combining licensed medical providers, pharmacy fulfilment, continuing patient monitoring and white-label health care infrastructure, Stealth Health is positioned at the intersection of telemedicine, precision wellness and the rapidly growing longevity market.

The Stealth Health platform serves patients across a range of precision medicine programs -- including hormone optimization, peptide therapy, GLP-1 weight management and anti-aging protocols, many of which require medications that are acutely sensitive to temperature fluctuations. Tempramed's patented, battery-free thermal insulation technology, engineered from space-grade materials, addresses this critical gap in the patient care journey, ensuring medication integrity from dispensing through daily use.

This partnership positions Tempramed within an active, physician-connected patient care environment, reinforcing Tempramed's commercialization strategy to build scalable adoption through trusted clinical and wellness channels. Stealth Health's dual-model business, combining direct-to-patient telemedicine and a white-label enterprise platform serving clinics, health care providers, and wellness brands, provides Tempramed with access to a B2C (business-to-business) platform and patient population.

Partnership highlights

  • Stealth Health is a leading telemedicine platform for longevity and precision wellness, now fully operational across all 50 U.S. states.
  • VIVI product portfolio will be recommended and distributed through Stealth Health's direct-to-patient telemedicine clinic and its enterprise white-label network of clinics and wellness brands.
  • Partnership addresses a critical unmet need: Stealth Health's patient population is prescribed temperature-sensitive medications including hormones, peptides and biologics.
  • Scalable channel supports sustained B2C (business-to-business) demand generation through Stealth Health's MSO-compliant, HIPAA-certified infrastructure across all 50 U.S. states.
  • Tempramed's positioning as a standard-of-care adjunct for temperature-sensitive medications is reinforced across an active, patient base.

"Stealth Health has built exactly the kind of patient ecosystem that is synergistic to our business and product portfolio. Their patients are already prescribed medications that are highly sensitive to temperature -- hormones, peptides, GLP-1s and we have a solution for these patients to keep these medications safe. A solution they may not know even exists," said Ron Nagar, chief executive officer of Tempramed. Partnering with Stealth Health gives us direct access to that population through a trusted clinical relationship, which is the most powerful driver of product adoption in health care. This is not just a distribution agreement, it is a pathway to meaningful, sustained patient engagement at scale."

"Our mission at Stealth Health is to deliver truly personalized, end-to-end care and that means addressing every factor that impacts medication effectiveness," said Matthew Mazzuca, chief executive officer of Stealth Health. "Tempramed's products are a natural fit for our patients who depend on temperature-sensitive treatments every single day. Whether they're managing their protocols at home or on the go, protecting the integrity of their medication is non-negotiable. This partnership reflects our commitment to giving patients the full toolkit they need to get results."

The partnership complements Tempramed's broader commercialization efforts across pharmacy, direct-to-consumer and enterprise channels, while opening new global distribution potential through Stealth Health's expanding white-label network of health care organizations and wellness brands.

About Tempramed Technologies Ltd.

Tempramed Technologies is a global leader in innovative, temperature-controlled medication storage solutions. Founded with the mission to safeguard the effectiveness of life-saving medications, Tempramed develops patented, Food and Drug Administration-registered, space-grade thermal insulation devices that work 24/seven without batteries or external power. With a proven product line including VIVI Cap and VIVI Epi, together with their proprietary smart technology platform, Tempramed enables patients and health care providers to manage temperature-sensitive medications anywhere, anytime, confidently. With operations in North America, Europe and Asia, Tempramed is advancing the future of medication protection and adherence.

About Stealth Health

Stealth Health is a leading telemedicine platform for longevity and precision wellness, with fully established U.S. operations across all 50 states since January, 2026. The company operates a dual-model business: a direct-to-patient telemedicine clinic offering personalized longevity programs including hormone optimization, peptide therapy and precision wellness protocols; and a white-label enterprise platform enabling health care organizations, clinics and wellness brands to deliver branded telemedicine services powered by Stealth Health's proven clinical infrastructure. Stealth Health's platform is supported by a management services organization (MSO) structure, HIPAA-compliant technology, board-certified physicians and licensed pharmacy partnerships.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.